Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
PhiTech logo — Multi-omics AI for Precision Medicine

PhiTech

Multi-omics AI for Precision Medicine

Founded 2013 Turkey Turkey 27 employees Total: $7.25M Biopharma, Biotechnology

General Information

Company Name PhiTech
Founded Year 2013
Location Turkey Turkey
Employees 27
Industries Biopharma, Biotechnology
Business Model B2B, SaaS, B2D
Revenue Model Subscription, Usage Based, Service Fee
Offices as of Oct 2026
Kocaeli, Turkey Chicago, United States Leiden, The Netherlands
Social

BounceWatch is an independent company data service, not affiliated with PhiTech. To contact PhiTech, visit phitech.bio.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does PhiTech compare?

A PDF of PhiTech and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting PhiTech soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Program Acceptance Sep 30, 2026

PhiTech has been selected for the Innogate USA Silicon Valley AI Program, where they will bring their AI solutions to the Silicon Valley ecosystem.

Award Received Sep 11, 2026

PhiTech was recently featured on Forbes Türkiye’s “Girişim 2026” list as a standout startup.

Get alerts when PhiTech shows new signals

About PhiTech

PhiTech, founded in 2013 and headquartered in Turkey, is at the forefront of biopharma innovation. Specializing in multi-omics AI, the company integrates DNA and RNA sequencing with artificial intelligence to advance diagnostics for rare diseases. This positions PhiTech uniquely within the Biopharma and Biotechnology industries.

The company's commitment to precision medicine is encapsulated in its slogan, "Multi-omics AI for Precision Medicine." With a focus on applying cutting-edge technology to genetic data, PhiTech is pioneering new pathways in the medical field.

The company's most recent financial milestone was securing a $2.40M Early VC investment on 01 April 2026. This injection of capital was led by a diverse group of investors including Arka Venture Labs, Eksim Ventures, Founder One, Enter Capital, İTK Ventures, IST Capital, TechnoBee, and Osman Alp Arlı. This backing underscores investor confidence in PhiTech's innovative approach and potential for significant industry impact.

Business keywords: Multi-omics, Precision Medicine, DNA Sequencing, RNA Sequencing, AI Diagnostics, Rare Disease Diagnostics, Bioinformatics, Genomics, Transcriptomics, Epigenomics, Healthcare Innovation, Disease Sequencing

Services & Products

Integrating genomics and transcriptomics for diagnosis
Automated gene prioritization
RNA-Seq data analysis
AI-driven interpretation of genetic data
Comprehensive diagnostic profiling

Target Customers

Diagnostic Laboratories Hospitals & Clinics Academic & Research Centers Biopharma Companies Contract Research Organizations (CROs)

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Early VC $2.40M 8
Arka Venture Labs Eksim Ventures Founder One
Arka Venture Labs, Eksim Ventures +6
01 Apr 2026
Early VC $500.00K 1
Eksim Ventures
Eksim Ventures
01 Sep 2025
Seed $1.10M 1
Arya Women's Investment Platform
Arya Women's Investment Platform
01 Mar 2024
Seed $250.00K 1
Arya Women's Investment Platform
Arya Women's Investment Platform
01 Nov 2023
Seed $3.00M 11
Omurga Capital
Omurga Capital, Sena Nomak +9
01 Mar 2023
Spinout Undisclosed 1
Boğaziçi University
01 Jan 2013

Latest News

View All
Eksim Ventures, SmartAlpha ve PhiTech'e yatırım yaptı — Webrazzi
Eksim Ventures, SmartAlpha ve PhiTech'e yatırım yaptı
Webrazzi Sep 18, 2025
Eksim Ventures dijital sağlıkta iki yatırıma imza attı — Aa.com.tr
Eksim Ventures dijital sağlıkta iki yatırıma imza attı
Aa.com.tr Sep 18, 2025
Genom ve yapay zeka teknolojilerini nadir hastalıklar için birleştiren PhiTech, 1.1 milyon dolar yat... — Webrazzi.com
Genom ve yapay zeka teknolojilerini nadir hastalıklar için birleştiren PhiTech, 1.1 milyon dolar yatırım aldı
Webrazzi.com Mar 08, 2024

PhiTech Alternatives & Competitors

View All Alternatives
PhiTech vs
Oxford Nanopore Technologies
Oxford Nanopore Technologies United Kingdom

Our goal is to enable the analysis of anything, by anyone, anywhere.

Post-IPO Equity
1341 employees
Biopharma, Biotechnology
PhiTech vs
PrognomiQ Inc
PrognomiQ Inc United States

Transform healthcare and early disease detection through the power of multi-omics data.

44 employees
Biopharma, Biotechnology
PhiTech vs
Genomics
Genomics United Kingdom

Transforming health, healthcare and drug discovery and development through the power of genomics

186 employees
Biopharma, Biotechnology
View all alternatives

FAQ About PhiTech

Multi-omics AI for Precision Medicine
PhiTech was founded in 2013.
PhiTech is headquartered in Turkey. As of Oct 2026, it also has offices in Kocaeli, Turkey, Chicago, United States and Leiden, The Netherlands.
PhiTech operates in Biopharma and Biotechnology. Its work centres on Multi-omics, Precision Medicine, DNA Sequencing and RNA Sequencing. Its customers include Diagnostic Laboratories, Hospitals & Clinics and Academic & Research Centers.
PhiTech has a B2B, SaaS and B2D business model. Its revenue comes from Subscription, Usage Based and Service Fee.
PhiTech has approximately 27 employees.
PhiTech has completed 6 funding rounds, raising a total of $7.25M.
PhiTech offers: Integrating genomics and transcriptomics for diagnosis, Automated gene prioritization, RNA-Seq data analysis, AI-driven interpretation of genetic data, Comprehensive diagnostic profiling.
Top alternatives and competitors to PhiTech include Oxford Nanopore Technologies, PrognomiQ Inc, Genomics, LCM Genect, MultiplAI Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PhiTech and Oxford Nanopore Technologies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for PhiTech, https://bouncewatch.com/company/phitech-bioinformatics, updated 23 August 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes